Remi Gaston-Dreyfus - Mar 29, 2021 Form 4 Insider Report for Bionik Laboratories Corp. (BNKL)

Role
Director, 10%+ Owner
Signature
/s/ Remi Gaston-Dreyfus
Stock symbol
BNKL
Transactions as of
Mar 29, 2021
Transactions value $
$0
Form type
4
Date filed
12/13/2021, 03:31 PM
Previous filing
Dec 13, 2021
Next filing
Dec 13, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNKL Common Stock, par value $0.001 per share Award +61.3K +4.32% 1.48M Mar 29, 2021 Shares held through RGD Investissements S.A.S. and Lombard International Assurance SA F1
holding BNKL Common Stock, par value $0.001 per share 61.3K Mar 29, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 For director fees.